Supriya Lifescience Limited
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.
What Supriya files
- Investor Meet52
- Others44
- Updates18
- Important10
- Board Meeting10
- PPTs7
Supriya Lifescience Limited is participating in a virtual group meeting with analysts and institutional investors to discuss business updates and company operations. An investor presentation has been made available on stock exchanges and the official website for reference.
Supriya Lifescience shares its FY25-26 Annual Report and details for its 18th AGM. Shareholders can access reports via the company website and stock exchanges; direct weblinks are sent to those without registered emails.
Supriya Lifescience reports no new developments in the ongoing legal matter concerning its General Manager – Sales & Marketing. The case remains in court, awaiting further hearing. The company will update investors on any material changes.
Supriya Lifescience Limited has informed the Exchange about Copy of Newspaper Publication
Supriya Lifescience Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026